Al-Dasooqi, N., Bowen, J.M., Gibson, R.J., Logan, R.M., Stringer, A.M. and Keefe, D.M., 2011. Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti rat. International Journal of Experimental Pathology 92: 357-365.

'Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti rat ' () 92 International Journal of Experimental Pathology : 357 -365.

Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti ratInternational Journal of Experimental Pathology92357365)| false
• Search Google Scholar

Alimonti, A., Gelibter, A., Pavese, I., Satta, F., Cognetti, F., Ferretti, G., Rasio, D., Vecchione, A. and Di Palma, M., 2004. New approaches to prevent intestinal toxicity of irinotecan-based regimens. Cancer Treatment Reviews 30: 555-562.

'New approaches to prevent intestinal toxicity of irinotecan-based regimens ' () 30 Cancer Treatment Reviews : 555 -562.

New approaches to prevent intestinal toxicity of irinotecan-based regimensCancer Treatment Reviews30555562)| false
• Search Google Scholar

Arifa, R.D., Madeira, M.F., de Paula, T.P., Lima, R.L., Tavares, L.D., Menezes-Garcia, Z., Fagundes, C.T., Rachid, M.A., Ryffel, B., Zamboni, D.S., Teixeira, M.M. and Souza, D.G., 2014. Inflammasome activation is reactive oxygen species dependent and mediates irinotecan-induced mucositis through IL-1β and IL-18 in mice. American Journal of Pathology 184: 2023-2034.

'Inflammasome activation is reactive oxygen species dependent and mediates irinotecan-induced mucositis through IL-1β and IL-18 in mice ' () 184 American Journal of Pathology : 2023 -2034.

Inflammasome activation is reactive oxygen species dependent and mediates irinotecan-induced mucositis through IL-1β and IL-18 in miceAmerican Journal of Pathology18420232034)| false
• Search Google Scholar

Bowen, J.M., Stringer, A.M., Gibson, R.J., Yeoh, A.S., Hannam, S. and Keefe, D.M., 2007. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biology & Therapy 6: 1449-1454.

'VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss ' () 6 Cancer Biology & Therapy : 1449 -1454.

VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight lossCancer Biology & Therapy614491454)| false
• Search Google Scholar

Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248-254.

'A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding ' () 72 Analytical Biochemistry : 248 -254.

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry72248254)| false
• Search Google Scholar

Brandi, G., Dabard, J., Raibaud, P., Di Battista, M., Bridonneau, C., Pisi, A.M., Morselli Labate, A.M., Pantaleo, M.A., De Vivo, A. and Biasco, G., 2006. Intestinal microflora and digestive toxicity of irinotecan in mice. Clinical Cancer Research 12: 1299-1307.

'Intestinal microflora and digestive toxicity of irinotecan in mice ' () 12 Clinical Cancer Research : 1299 -1307.

Intestinal microflora and digestive toxicity of irinotecan in miceClinical Cancer Research1212991307)| false
• Search Google Scholar

Brestoff, J.R. and Artis, D., 2013. Commensal bacteria at the interface of host metabolism and the immune system. Nature Immunology 14: 676-684.

'Commensal bacteria at the interface of host metabolism and the immune system ' () 14 Nature Immunology : 676 -684.

Commensal bacteria at the interface of host metabolism and the immune systemNature Immunology14676684)| false
• Search Google Scholar

Buccigrossi, V., Laudiero, G., Russo, C., Miele, E., Sofia, M., Monini, M., Ruggeri, F.M. and Guarino, A., 2014. Chloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytes. PloS One 9: e99830.

'Chloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytes ' () 9 PloS One : e99830.

Chloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytesPloS One9e99830)| false
• Search Google Scholar

Cesaro, S., Chinello, P., Rossi, L. and Zanesco, L., 2000. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Supportive Care in Cancer 8: 504-505.

'Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii ' () 8 Supportive Care in Cancer : 504 -505.

Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardiiSupportive Care in Cancer8504505)| false
• Search Google Scholar

Chen, S., Yueh, M.F., Bigo, C., Barbier, O., Wang, K., Karin, M., Nguyen, N. and Tukey, R.H., 2013. Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11). Proceedings of the National Academy of Sciences of the USA 110: 19143-19148.

Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11) Proceedings of the National Academy of Sciences of the USA 110 19143 19148

Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11)Proceedings of the National Academy of Sciences of the USA1101914319148)| false
• Search Google Scholar

De Freitas Cuba, L., Salum, F.G., Cherubini, K. and de Figueiredo, M.A., 2015. Antioxidant agents: a future alternative approach in the prevention and treatment of radiation-induced oral mucositis? Alternative Therapies in Health and Medicine 21: 36-41.

'Antioxidant agents: a future alternative approach in the prevention and treatment of radiation-induced oral mucositis? ' () 21 Alternative Therapies in Health and Medicine : 36 -41.

Antioxidant agents: a future alternative approach in the prevention and treatment of radiation-induced oral mucositis?Alternative Therapies in Health and Medicine213641)| false
• Search Google Scholar

Draper, H.H. and Hadley, M., 1990. Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 186: 421-431.

'Malondialdehyde determination as index of lipid peroxidation ' () 186 Methods in Enzymology : 421 -431.

Malondialdehyde determination as index of lipid peroxidationMethods in Enzymology186421431)| false
• Search Google Scholar

Duman, D.G., Kumral, Z.N., Ercan, F., Deniz, M., Can, G. and Cağlayan Yeğen, B., 2013. Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats. British Journal of Nutrition 110: 493-499.

'Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats ' () 110 British Journal of Nutrition : 493 -499.

Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in ratsBritish Journal of Nutrition110493499)| false
• Search Google Scholar

Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 82: 70-77.

'Tissue sulfhydryl groups ' () 82 Archives of Biochemistry and Biophysics : 70 -77.

Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics827077)| false
• Search Google Scholar

Flieger, D., Klassert, C., Hainke, S., Keller, R., Kleinschmidt, R. and Fischbach, W., 2007. Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma. Oncology 72: 10-16.

'Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma ' () 72 Oncology : 10 -16.

Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinomaOncology721016)| false
• Search Google Scholar

Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on draftingguidelines for the evaluation of probiotics in food. Available at: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.

Generoso, S.V., Viana, M., Santos, R., Martins, F.S., Machado, J.A., Arantes, R.M., Nicoli, J.R., Correia, M.I. and Cardoso, V.N., 2010. Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Archives of Microbiology 192: 477-484.

'Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model ' () 192 Archives of Microbiology : 477 -484.

Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction modelArchives of Microbiology192477484)| false
• Search Google Scholar

Gibson, R.J. and Stringer, A.M., 2009. Chemotherapy-induced diarrhoea. Current Opinion Support Palliat Care 3: 31-35.

'Chemotherapy-induced diarrhoea ' () 3 Current Opinion Support Palliat Care : 31 -35.

Chemotherapy-induced diarrhoeaCurrent Opinion Support Palliat Care33135)| false
• Search Google Scholar

Gibson, R.J., Bowen, J.M., Inglis, M.R., Cummins, A.G. and Keefe, D.M., 2003. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. Journal of Gastroenterology and Hepatology 18: 1095-1100.

'Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer ' () 18 Journal of Gastroenterology and Hepatology : 1095 -1100.

Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancerJournal of Gastroenterology and Hepatology1810951100)| false
• Search Google Scholar

Ishii, Y., Sugimoto, S., Izawa, N., Sone, T., Chiba, K. and Miyazaki, K., 2014. Oral administration of Bifidobacterium breve attenuates UV-induced barrier perturbation and oxidative stress in hairless mice skin. Archives of Dermatological Research 306: 467-473.

'Oral administration of Bifidobacterium breve attenuates UV-induced barrier perturbation and oxidative stress in hairless mice skin ' () 306 Archives of Dermatological Research : 467 -473.

Oral administration of Bifidobacterium breve attenuates UV-induced barrier perturbation and oxidative stress in hairless mice skinArchives of Dermatological Research306467473)| false
• Search Google Scholar

Javle, M.M., Cao, S., Durrani, F.A., Pendyala, L., Lawrence, D.D., Smith, P.F., Creaven, P.J., Noel, D.C., Iyer, R.V. and Rustum, Y.M., 2007. Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracil. Clinical Cancer Research 13: 965-971.

'Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracil ' () 13 Clinical Cancer Research : 965 -971.

Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracilClinical Cancer Research13965971)| false
• Search Google Scholar

Justino, P.F., Melo, L.F., Nogueira, A.F., Costa, J.V., Silva, L.M., Santos, C.M., Mendes, W.O., Costa, M.R., Franco, A.X., Lima, A.A., Ribeiro, R.A., Souza, M.H. and Soares, P.M., 2014. Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice. British Journal of Nutrition 111: 1611-1621.

'Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice ' () 111 British Journal of Nutrition : 1611 -1621.

Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in miceBritish Journal of Nutrition11116111621)| false
• Search Google Scholar

Kaushal, D. and Kansal, V.K., 2012. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum alleviates age-inflicted oxidative stress and improves expression of biomarkers of ageing in mice. Molecular Biology Reports 39: 1791-1799.

'Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum alleviates age-inflicted oxidative stress and improves expression of biomarkers of ageing in mice ' () 39 Molecular Biology Reports : 1791 -1799.

Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum alleviates age-inflicted oxidative stress and improves expression of biomarkers of ageing in miceMolecular Biology Reports3917911799)| false
• Search Google Scholar

Kehrer, D.F., Sparreboom, A., Verweij, J., de Bruijn, P., Nierop, C.A., van de Schraaf, J., Ruijgrok, E.J. and De Jonge, M.J., 2001. Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients. Clinical Cancer Research 7: 1136-1141.

'Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients ' () 7 Clinical Cancer Research : 1136 -1141.

Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patientsClinical Cancer Research711361141)| false
• Search Google Scholar

Kweekel, D., Guchelaar, H.J. and Gelderblom, H., 2008. Clinical and pharmacogenetic factors associated with irinotecan toxicity. Cancer Treatment Reviews 34: 656-669.

'Clinical and pharmacogenetic factors associated with irinotecan toxicity ' () 34 Cancer Treatment Reviews : 656 -669.

Clinical and pharmacogenetic factors associated with irinotecan toxicityCancer Treatment Reviews34656669)| false
• Search Google Scholar

Liong, M.T., 2008. Safety of probiotics: translocation and infection. Nutrition Reviews 66: 192-202.

'Safety of probiotics: translocation and infection ' () 66 Nutrition Reviews : 192 -202.

Safety of probiotics: translocation and infectionNutrition Reviews66192202)| false
• Search Google Scholar

Logan, R.M., Stringer, A.M., Bowen, J.M., Yeoh, A.S., Gibson, R.J., Sonis, S.T. and Keefe, D.M., 2007. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treatment Reviews 33: 448-460.

'The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs ' () 33 Cancer Treatment Reviews : 448 -460.

The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugsCancer Treatment Reviews33448460)| false
• Search Google Scholar

Maioli, T.U., De Melo Silva, B., Dias, M.N., Paiva, N.C., Cardoso, V.N., Fernandes, S.O., Carneiro, C.M., Dos Santos Martins, F. and De Vasconcelos Generoso, S., 2014. Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice. Journal of Negative Results in Biomedicine 13: 6.

'Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice ' () 13 Journal of Negative Results in Biomedicine : 6.

Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss miceJournal of Negative Results in Biomedicine136)| false
• Search Google Scholar

Martins, F.S., Elian, S.D., Vieira, A.T., Tiago, F.C., Martins, A.K., Silva, F.C., Souza, E.L., Sousa, L.P., Araújo, H.R., Pimenta, P.F., Bonjardim, C.A., Arantes, R.M., Teixeira, M.M. and Nicoli, J.R., 2011. Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever. International Journal of Medical Microbiology 301: 359-364.

'Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever ' () 301 International Journal of Medical Microbiology : 359 -364.

Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid feverInternational Journal of Medical Microbiology301359364)| false
• Search Google Scholar

Martins, F.S., Nardi, R.M., Arantes, R.M., Rosa, C.A., Neves, M.J. and Nicoli, J.R., 2005. Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. Journal of General and Applied Microbiology 51: 83-92.

'Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice ' () 51 Journal of General and Applied Microbiology : 83 -92.

Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in miceJournal of General and Applied Microbiology518392)| false
• Search Google Scholar

Martins, F.S., Rodrigues, A.C., Tiago, F.C., Penna, F.J., Rosa, C.A., Arantes, R.M., Nardi, R.M., Neves, M.J. and Nicoli, J.R., 2007. Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. Journal of Medical Microbiology 56: 352-359.

'Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice ' () 56 Journal of Medical Microbiology : 352 -359.

Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional miceJournal of Medical Microbiology56352359)| false
• Search Google Scholar

Mishra, V., Shah, C., Mokashe, N., Chavan, R., Yadav, H. and Prajapati, J., 2015. Probiotics as potential antioxidants: a systematic review. Journal of Agricultural and Food Chemistry 63: 3615-3626.

'Probiotics as potential antioxidants: a systematic review ' () 63 Journal of Agricultural and Food Chemistry : 3615 -3626.

Probiotics as potential antioxidants: a systematic reviewJournal of Agricultural and Food Chemistry6336153626)| false
• Search Google Scholar

Pedroso, S.H., Vieira, A.T., Bastos, R.W., Oliveira, J.S., Cartelle, C.T., Arantes, R.E., Soares, P.G., Generoso, S.V., Cardoso, V.N., Teixeira, M.M., Nicoli, J.R. and Martins, F.S., 2015. Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice. Microbiology 161: 1950-1960.

'Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice ' () 161 Microbiology : 1950 -1960.

Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free miceMicrobiology16119501960)| false
• Search Google Scholar

Pico, J.L., Avila-Garavito, A. and Naccache, P., 1998. Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting. Oncologist 3: 446-451.

'Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting ' () 3 Oncologist : 446 -451.

Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology SettingOncologist3446451)| false
• Search Google Scholar

Pommier, Y., 2006. Topoisomerase I inhibitors: camptothecins and beyond. Nature Reviews Cancer 6: 789-802.

'Topoisomerase I inhibitors: camptothecins and beyond ' () 6 Nature Reviews Cancer : 789 -802.

Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer6789802)| false
• Search Google Scholar

Sezer, A., Usta, U. and Cicin, I., 2009. The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea. Medical Oncology 26: 350-357.

'The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea ' () 26 Medical Oncology : 350 -357.

The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrheaMedical Oncology26350357)| false
• Search Google Scholar

Stringer, A.M., Gibson, R.J., Bowen, J.M., Logan, R.M., Ashton, K., Yeoh, A.S., Al-Dasooqi, N. and Keefe, D.M., 2009a. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. International Journal of Experimental Pathology 90: 489-499.

'Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile ' () 90 International Journal of Experimental Pathology : 489 -499.

Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profileInternational Journal of Experimental Pathology90489499)| false
• Search Google Scholar

Stringer, A.M., Gibson, R.J., Logan, R.M., Bowen, J.M., Yeoh, A.S., Laurence, J. and Keefe, D.M., 2009b. Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemotherapy and Pharmacology 64: 123-132.

'Irinotecan-induced mucositis is associated with changes in intestinal mucins ' () 64 Cancer Chemotherapy and Pharmacology : 123 -132.

Irinotecan-induced mucositis is associated with changes in intestinal mucinsCancer Chemotherapy and Pharmacology64123132)| false
• Search Google Scholar

Takasuna, K., Hagiwara, T., Hirohashi, M., Kato, M., Nomura, M., Nagai, E., Yokoi, T. and Kamataki, T., 1998. Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats. Cancer Chemotherapy and Pharmacology 42: 280-286.

'Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats ' () 42 Cancer Chemotherapy and Pharmacology : 280 -286.

Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in ratsCancer Chemotherapy and Pharmacology42280286)| false
• Search Google Scholar

Tiago, F.C., Martins, F.S., Souza, E.L., Pimenta, P.F., Araujo, H.R., Castro, I.M., Brandão, R.L. and Nicoli, J.R., 2012. Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. Journal of Medical Microbiology 61: 1194-1207.

'Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics ' () 61 Journal of Medical Microbiology : 1194 -1207.

Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probioticsJournal of Medical Microbiology6111941207)| false
• Search Google Scholar

Tiago, F.C., Porto, B.A., Ribeiro, N.S., Moreira, L.M., Arantes, R.M., Vieira, A.T., Teixeira, M.M., Generoso, S.V., Nascimento, V.N., Martins, F.S. and Nicoli, J.R., 2015. Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease. Beneficial Microbes 6: 807-815.

'Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease ' () 6 Beneficial Microbes : 807 -815.

Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel diseaseBeneficial Microbes6807815)| false
• Search Google Scholar

Vieira, A.T., Teixeira, M.M. and Martins, F.S., 2013. The role of probiotics and prebiotics in inducing gut immunity. Frontiers in Immunology 4: 445.

'The role of probiotics and prebiotics in inducing gut immunity ' () 4 Frontiers in Immunology : 445.

The role of probiotics and prebiotics in inducing gut immunityFrontiers in Immunology4445)| false
• Search Google Scholar

Wallace, B.D., Wang, H., Lane, K.T., Scott, J.E., Orans, J., Koo, J.S., Venkatesh, M., Jobin, C., Yeh, L.A., Mani, S. and Redinbo, M.R., 2010. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330: 831-835.

'Alleviating cancer drug toxicity by inhibiting a bacterial enzyme ' () 330 Science : 831 -835.

Alleviating cancer drug toxicity by inhibiting a bacterial enzymeScience330831835)| false
• Search Google Scholar

Wirtz, S., Neufert, C., Weigmann, B. and Neurath, M.F., 2007. Chemically induced mouse models of intestinal inflammation. Nature Protocols 2: 541-546.

'Chemically induced mouse models of intestinal inflammation ' () 2 Nature Protocols : 541 -546.

Chemically induced mouse models of intestinal inflammationNature Protocols2541546)| false
• Search Google Scholar

Zwielehner, J., Lassl, C., Hippe, B., Pointner, A., Switzeny, O.J., Remely, M., Kitzweger, E., Ruckser, R. and Haslberger, A.G., 2011. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PloS One 6: e28654.

'Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting ' () 6 PloS One : e28654.

Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprintingPloS One6e28654)| false
• Search Google Scholar